GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,568,000 | -69.9% | 11,800 | -83.9% | 0.00% | -69.2% |
| Q4 2020 | $8,533,000 | +9.2% | 73,508 | -8.0% | 0.01% | -27.8% |
| Q3 2020 | $7,813,000 | +3.6% | 79,864 | +29.1% | 0.02% | -14.3% |
| Q2 2020 | $7,539,000 | +11.5% | 61,840 | -22.1% | 0.02% | 0.0% |
| Q1 2020 | $6,764,000 | -51.9% | 79,410 | -42.4% | 0.02% | -38.2% |
| Q4 2019 | $14,064,000 | -1.9% | 137,876 | +12.0% | 0.03% | -19.0% |
| Q3 2019 | $14,332,000 | +38.6% | 123,118 | +105.3% | 0.04% | +44.8% |
| Q2 2019 | $10,338,000 | +11.6% | 59,973 | -27.0% | 0.03% | +31.8% |
| Q2 2018 | $9,262,000 | 0.0% | 82,209 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $9,262,000 | -20.2% | 82,209 | -6.5% | 0.02% | -47.6% |
| Q4 2017 | $11,605,000 | +33.4% | 87,917 | +2.6% | 0.04% | +27.3% |
| Q3 2017 | $8,697,000 | -4.2% | 85,685 | -5.8% | 0.03% | -19.5% |
| Q2 2017 | $9,083,000 | -14.9% | 90,944 | +3.4% | 0.04% | -30.5% |
| Q1 2017 | $10,678,000 | -17.6% | 87,991 | -24.1% | 0.06% | -7.8% |
| Q4 2016 | $12,963,000 | +7.4% | 116,000 | +24.9% | 0.06% | +14.3% |
| Q3 2016 | $12,074,000 | +182.2% | 92,900 | +102.4% | 0.06% | +133.3% |
| Q2 2016 | $4,278,000 | – | 45,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|